Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Ultragenyx Pharmaceutical Inc    RARE

ULTRAGENYX PHARMACEUTICAL INC (RARE)
My previous session
Most popular
  Report  
Delayed Quote. Delayed  - 12/14 10:00:04 pm
46.01 USD   -2.75%
2014Amid Alibaba fever, reasons for caution in IPO market
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations
Sector news Bio Therapeutic Drugs
12/14FDA Approves Herceptin Biosimilar Herzuma
DJ
12/13Lilly, Incyte Get FDA Fast-Track Designation for Baricitinib in Systemic Lupu..
DJ
12/10Almost half of S&P 500 stocks in a bear market
RE
12/10ROCHE : Gilead Sciences snares Roche veteran O'Day as CEO
RE
12/10LONZA : to Establish Biomanufacturing Base in China
DJ
12/10Roche Pharmaceuticals Names New CEO as O'Day Leaves to Head Gilead -- Update
DJ
12/10Roche Executive Named Gilead CEO -- 2nd Update
DJ
12/10Gilead Taps Roche Veteran as New CEO -- WSJ
DJ
12/10Roche Executive to Be Named Gilead CEO -- Update
DJ
12/10Roche Executive to Be Named Gilead CEO
DJ
12/08Moderna Declines in Market Debut -- WSJ
DJ
12/07Moderna Declines in Public-Market Debut
DJ
12/07GILEAD SCIENCES : U.K.'s NICE Recommends Gilead CAR-T Therapy, Reversing Earlier..
DJ
12/04Amgen antibody shows promise in myeloma trial, gets FDA fast track
RE
11/28FDA Approves Celltrion's Truxima As Biosimilar to Genentech's Rituxan
DJ
11/21Oil, Tech Stocks Help Turn Around S&P Selloff
DJ
11/12Ziopharm in Supply Agreement with Regeneron to Study Glioblastoma Treatment
DJ
11/06Regeneron, Sanofi Get FDA Priority Review for Dupixent in Adolescents
DJ
11/06REGENERON PHARMACEUTICALS : Posts Higher Profits Led By Treatment Advances
DJ
11/06REGENERON PHARMACEUTICALS : Sanofi and Regeneron's Dupixent gets more positive f..
RE
11/01LONZA : sells water care business for $630 million
RE
10/31GILEAD SCIENCES : In Cancer Collaboration With Tango Therapeutics
DJ
10/31Vaccines and Genzyme help Sanofi keep promise of return to growth
RE
10/29Drugmakers tout new medicines as eye disease battle intensifies
RE
10/29Novartis, Pfizer join forces on potentially lucrative fatty liver disease
RE
10/25GILEAD SCIENCES : Raises Annual Product-Sales Forecast Following Earnings Beat
DJ
10/25Ditch the Ping Pong Table' and Other Tips for Making the Workplace Better
DJ
10/24AbbVie Takes Over Cystic Fibrosis Programs From Galapagos
DJ
10/19FDA Approves Asthma Indication for Regeneron and Sanofi's Dupixent
DJ
10/16Sanofi's Dupixent Shows Positive Headline Results in Two Phase 3 Studies
DJ
10/11GILEAD SCIENCES : Allogene's Upsized IPO Prices at High End of Range
DJ
10/05ABBVIE : Receives Health Canada Approval of Orilissa for Endometriosis Pain Trea..
DJ
10/04J&J, Arrowhead in gene-silencing drug deal worth up to $3.7 billion
RE
10/02GILEAD SCIENCES : Allogene Sets IPO at 16 Million Shares; Sees Pricing $16-$18
DJ
09/28FDA Approves Libtayo to Treat Advanced Cutaneous Squamous Cell Carcinoma
DJ
09/27Novartis strikes deal with Chinese firm to make Kymriah
RE
09/27Novartis strikes deal with Chinese firm to make Kymriah
RE
09/24GILEAD SCIENCES : to Slice List Prices of Liver Drugs -- 2nd Update
DJ
09/24GILEAD SCIENCES : to Slice List Prices of Liver Drugs -- Update
DJ
09/24GILEAD SCIENCES : to Slice List Prices of Liver Drugs
DJ
09/19NOVARTIS : U.K. Pulls Brakes on Novartis' CAR-T Drug in First European Setback -..
DJ
09/19NOVARTIS : U.K. Pulls Brakes on Novartis' CAR-T Drug for Some Patients Despite D..
DJ
09/19GILEAD SCIENCES : UK rejects adult Novartis CAR-T therapy, after 'yes' in kids
RE
09/18REGENERON PHARMACEUTICALS : Sanofi pledges to keep up its restructuring efforts
RE
09/14Allogene, Which Announced Pfizer Agreement in April, Discloses IPO Plans
DJ
09/14Allogene, Which Announced Pfizer Agreement in April, Discloses IPO Plans -- U..
DJ
09/13Roche steps up efficiency drive to take sting out of biosimilars
RE
09/12EUROPE : European stocks shrug off trade worries as oil stocks rally
RE
09/12Galapagos, Gilead bask in $4-6 billion new drug sales hope
RE
09/12GILEAD SCIENCES : Precision BioSciences Developing Hepatitis B Therapies
DJ
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on ULTRAGENYX PHARMACEUTICAL